Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
PLoS Pathog ; 19(4): e1011321, 2023 04.
Article in English | MEDLINE | ID: mdl-37068092

ABSTRACT

Group A Streptococcus (GAS, Streptococcus pyogenes) is a professional human pathogen that commonly infects the skin. Keratinocytes are one of the first cells to contact GAS, and by inducing inflammation, they can initiate the earliest immune responses to pathogen invasion. Here, we characterized the proinflammatory cytokine repertoire produced by primary human keratinocytes and surrogate cell lines commonly used in vitro. Infection induces several cytokines and chemokines, but keratinocytes constitutively secrete IL-18 in a form that is inert (pro-IL-18) and lacks proinflammatory activity. Canonically, IL-18 activation and secretion are coupled through a single proteolytic event that is regulated intracellularly by the inflammasome protease caspase-1 in myeloid cells. The pool of extracellular pro-IL-18 generated by keratinocytes is poised to sense extracellular proteases. It is directly processed into a mature active form by SpeB, a secreted GAS protease that is a critical virulent factor during skin infection. This mechanism contributes to the proinflammatory response against GAS, resulting in T cell activation and the secretion of IFN-γ. Under these conditions, isolates of several other major bacterial pathogens and microbiota of the skin were found to not have significant IL-18-maturing ability. These results suggest keratinocyte-secreted IL-18 is a sentinel that sounds an early alarm that is highly sensitive to GAS, yet tolerant to non-invasive members of the microbiota.


Subject(s)
Bacterial Infections , Interleukin-18 , Humans , Bacterial Infections/metabolism , Cytokines/metabolism , Inflammation , Interleukin-18/metabolism , Keratinocytes/metabolism , Peptide Hydrolases/metabolism
2.
Infect Immun ; 88(10)2020 09 18.
Article in English | MEDLINE | ID: mdl-32719155

ABSTRACT

Group A Streptococcus (GAS) is the etiologic agent of numerous high-morbidity and high-mortality diseases. Infections are typically highly proinflammatory. During the invasive infection necrotizing fasciitis, this is in part due to the GAS protease SpeB directly activating interleukin-1ß (IL-1ß) independent of the canonical inflammasome pathway. The upper respiratory tract is the primary site for GAS colonization, infection, and transmission, but the host-pathogen interactions at this site are still largely unknown. We found that in the murine nasopharynx, SpeB enhanced IL-1ß-mediated inflammation and the chemotaxis of neutrophils. However, neutrophilic inflammation did not restrict infection and instead promoted GAS replication and disease. Inhibiting IL-1ß or depleting neutrophils, which both promote invasive infection, prevented GAS infection of the nasopharynx. Mice pretreated with penicillin became more susceptible to GAS challenge, and this reversed the attenuation from neutralization or depletion of IL-1ß, neutrophils, or SpeB. Collectively, our results suggest that SpeB is essential to activate an IL-1ß-driven neutrophil response. Unlike during invasive tissue infections, this is beneficial in the upper respiratory tract because it disrupts colonization resistance mediated by the microbiota. This provides experimental evidence that the notable inflammation of strep throat, which presents with significant swelling, pain, and neutrophil influx, is not an ineffectual immune response but rather is a GAS-directed remodeling of this niche for its pathogenic benefit.


Subject(s)
Nasopharynx/immunology , Receptors, Interleukin-1 Type I/immunology , Signal Transduction/immunology , Streptococcal Infections/immunology , Streptococcus pyogenes/pathogenicity , Animals , Anti-Bacterial Agents/adverse effects , Bacterial Proteins/genetics , Bacterial Proteins/immunology , Caspase 1/genetics , Caspase 1/immunology , Chemotaxis, Leukocyte , Exotoxins/genetics , Exotoxins/immunology , Inflammation , Interleukin 1 Receptor Antagonist Protein/pharmacology , Interleukin-1beta/immunology , Mice , Nasopharynx/microbiology , Neutrophils/immunology , Pharyngitis/genetics , Pharyngitis/immunology , Pharyngitis/microbiology , Receptors, Interleukin-1 Type I/genetics , Signal Transduction/drug effects , Streptococcal Infections/genetics , Streptococcal Infections/microbiology , Streptococcus pyogenes/drug effects , Streptococcus pyogenes/genetics , Streptococcus pyogenes/growth & development , Virulence/drug effects , Virulence/genetics
3.
Microbiology (Reading) ; 164(7): 998-1003, 2018 07.
Article in English | MEDLINE | ID: mdl-29813015

ABSTRACT

Hypervirulent atypical El Tor biotype Vibrio cholerae O1 isolates harbour mutations in the DNA-binding domain of the nucleoid-associated protein H-NS and the receiver domain of the response regulator VieA. Here, we provide two examples in which inactivation of H-NS in El Tor biotype vibrios unmasks hidden regulatory connections. First, deletion of the helix-turn-helix domain of VieA in an hns mutant background diminished biofilm formation and exopolysaccharide gene expression, a function that phenotypically opposes its phosphodiesterase activity. Second, deletion of vieA in an hns mutant diminished the expression of σE, a virulence determinant that mediates the envelope stress response. hns mutants were highly sensitive to envelope stressors compared to wild-type. However, deletion of vieA in the hns mutant restored or exceeded wild-type resistance. These findings suggest an evolutionary path for the emergence of hypervirulent strains starting from nucleotide sequence diversification affecting the interaction of H-NS with DNA.


Subject(s)
Bacterial Proteins/genetics , DNA-Binding Proteins/genetics , Gene Expression Regulation, Bacterial , Vibrio cholerae O1/genetics , Vibrio cholerae O1/pathogenicity , Biofilms/growth & development , Gene Deletion , Mutation , Polysaccharides, Bacterial/genetics , Sigma Factor/genetics , Stress, Physiological/genetics , Vibrio cholerae O1/physiology , Virulence/genetics
4.
BMC Immunol ; 15: 584, 2014 Dec 31.
Article in English | MEDLINE | ID: mdl-25551828

ABSTRACT

BACKGROUND: We previously showed that the Vibrio cholerae ghost platform (VCG; empty V. cholerae cell envelopes) is an effective delivery system for vaccine antigens promoting the induction of substantial immunity in the absence of external adjuvants. However, the mechanism by which these cell envelopes enhance immunity and stimulate a predominantly Th1 cellular and humoral immune response has not been elucidated. We hypothesized that the immunostimulatory ability of VCG involves dendritic cell (DC) activation. OBJECTIVE: The aims of this study were: a) to investigate the ability of DCs [using mouse bone marrow-derived DCs (BMDCs) as a model system] to take up and internalize VCGs; b) to evaluate the immunomodulatory effect of internalized VCGs on DC activation and maturation and their functional capacity to present chlamydial antigen to naïve and infection-sensitized CD4+ T cells and; c) to evaluate the ability of VCGs to enhance the protective immunity of a chlamydial antigen. RESULTS: VCGs were efficiently internalized by DCs without affecting their viability and modulated DC-mediated immune responses. VCG-pulsed DCs showed increased secretion of proinflammatory cytokines and expression of co-stimulatory molecules associated with DC maturation in response to stimulation with UV-irradiated chlamydial elementary bodies (UV-EBs). Furthermore, this interaction resulted in effective chlamydial antigen presentation to infection-sensitized but not naïve CD4+ T cells and enhancement of protective immunity. CONCLUSIONS: The present study demonstrated that VCGs activate DCs leading to the surface expression of co-stimulatory molecules associated with DC activation and maturation and enhancement of protective immunity induced by a chlamydial antigen. The results indicate that the immunoenhancing activity of VCG for increased T-cell activation against antigens is mediated, at least in part, through DC triggering. Thus, VCGs could be harnessed as immunomodulators to target antigens to DCs for enhancement of protective immunity against microbial infections.


Subject(s)
Antigen Presentation , Antigens, Bacterial , Chlamydia trachomatis , Dendritic Cells/immunology , Th1 Cells/immunology , Vibrio cholerae , Animals , Antigens, Bacterial/chemistry , Antigens, Bacterial/immunology , Chlamydia trachomatis/chemistry , Chlamydia trachomatis/immunology , Female , HeLa Cells , Humans , Lymphocyte Activation , Mice , Vibrio cholerae/chemistry , Vibrio cholerae/immunology
SELECTION OF CITATIONS
SEARCH DETAIL